Baxter International | BAX - Market Capitalization

Stock Price
21.58
Daily Change
0.24 1.12%
Monthly
9.49%
Yearly
-36.19%
Q1 Forecast
20.91

Baxter International reported $10.89B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
AngioDynamics USD 278M 102M Jun/2025
AtriCure USD 1.61B 360M Feb/2026
Avanos Medical USD 536M 30M Sep/2025
Baxter International USD 9.54B 279M Feb/2026
Becton, Dickinson and Co. USD 51.01B 4.28B Feb/2026
Boston Scientific USD 110.32B 31.04B Feb/2026
Cooper Companies USD 13.9B 205M Sep/2025
Dexcom USD 25.44B 449M Feb/2026
Edwards Lifesciences USD 44.75B 4.72B Feb/2026
Fresenius EUR 26.7B 2.66B Sep/2025
Globus Medical USD 7.74B 255M Sep/2025
Halozyme Therapeutics USD 10.23B 2.31B Feb/2026
ICU Medical USD 3.62B 93M Feb/2026
Inogen USD 121M 146M Sep/2023
Insulet USD 18.05B 1.95B Feb/2026
Integra LifeSciences USD 1.12B 163M Sep/2025
Intuitive Surgical USD 200.77B 40.45B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Laboratory Of America USD 23.27B 2.47B Feb/2026
Masimo USD 7.68B 1.44B Sep/2025
Medtronic USD 116.51B 12.82B Feb/2026
Merit Medical Systems USD 4.93B 591M Sep/2025
Quest Diagnostics USD 23.09B 3.79B Feb/2026
Smith & Nephew USD 3.93B 9.39B Jan/2026
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.21B 278M Feb/2026
Teleflex USD 5.3B 73M Sep/2025
Terumo JPY 2.97T 651.71B Feb/2026
Zimmer Biomet Holdings USD 19.82B 2B Feb/2026